Showing results (241-250 of 593) with videos related to
Sort By:
Pageof 60
Antiviral Research|April 6, 2017
The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivoEmanuel Haasbach, Christin Müller, Christina Ehrhardt, et al.Annals of Intensive Care|September 30, 2025
Circulating biomarkers of vasoplegia: a systematic reviewNaomi Boyer, Prateek Upadhyay, Megan H Hicks, et al.Journal of Ethnopharmacology|May 15, 2016
Antiviral activity of hydroalcoholic extract from Eupatorium perfoliatum L. against the attachment of influenza A virusAndrea Derksen, Joachim Kühn, Wali Hafezi, et al.Npj Viruses|April 28, 2025
Metabolic interference impairs influenza A virus replication by dampening vRNA synthesisJens Kleinehr, Chiara Robin Bojarzyn, Michael Schöfbänker, et al.Journal of the American Society of Nephrology : JASN|December 3, 2017
Long-Term Clinical Outcomes after Early Initiation of RRT in Critically Ill Patients with AKIMelanie Meersch, Mira Küllmar, Christoph Schmidt, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2008
IL-17A inhibits the expansion of IL-17A-producing T cells in mice through "short-loop" inhibition via IL-17 receptorEmily Smith, Matthew A Stark, Alexander Zarbock, et al.Nature Communications|April 29, 2014
Annexin A8 controls leukocyte recruitment to activated endothelial cells via cell surface delivery of CD63Michaela Poeter, Ines Brandherm, Jan Rossaint, et al.Plos One|October 25, 2014
Validation of cell-cycle arrest biomarkers for acute kidney injury after pediatric cardiac surgeryMelanie Meersch, Christoph Schmidt, Hugo Van Aken, et al.BMJ Open|January 24, 2019
Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill patients with acute kidney injury (RICH) trial: study protocol for a multicentre, randomised controlled trialMelanie Meersch, Mira Küllmar, Carola Wempe, et al.Critical Care (London, England)|November 1, 2022
Proenkephalin A 119-159 predicts early and successful liberation from renal replacement therapy in critically ill patients with acute kidney injury: a post hoc analysis of the ELAIN trialThilo von Groote, Felix Albert, Melanie Meersch, et al.Pageof 60